{"id":2105,"date":"2022-05-02T03:33:37","date_gmt":"2022-05-02T03:33:37","guid":{"rendered":"https:\/\/bukka.phar.kyushu-u.ac.jp\/?post_type=publication&#038;p=2105"},"modified":"2023-05-02T03:34:08","modified_gmt":"2023-05-02T03:34:08","slug":"ethoxyquin-is-a-competent-radical-trapping-antioxidant-for-preventing-ferroptosis-in-doxorubicin-cardiotoxicity","status":"publish","type":"publication","link":"https:\/\/bukka.phar.kyushu-u.ac.jp\/en\/publication\/ethoxyquin-is-a-competent-radical-trapping-antioxidant-for-preventing-ferroptosis-in-doxorubicin-cardiotoxicity\/","title":{"rendered":"Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity"},"content":{"rendered":"<div class=\"publication_wrap\">\n\t<h3><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35881422\/\" target=\"_blank\">Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity<\/a><\/h3>\n\t\n  Tadokoro T, Ikeda M, Abe K, Ide T, Miyamoto HD, Furusawa S, Ishimaru K, Watanabe M, Ishikita A, Matsushima S, Koumura T, Yamada KI, Imai H, Tsutsui H<br>\n  <em>J Cardiovasc Pharmacol<\/em>\n  80(5):690-699,2022<\/div>","protected":false},"featured_media":0,"template":"","_links":{"self":[{"href":"https:\/\/bukka.phar.kyushu-u.ac.jp\/wp-json\/wp\/v2\/publication\/2105"}],"collection":[{"href":"https:\/\/bukka.phar.kyushu-u.ac.jp\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/bukka.phar.kyushu-u.ac.jp\/wp-json\/wp\/v2\/types\/publication"}],"version-history":[{"count":1,"href":"https:\/\/bukka.phar.kyushu-u.ac.jp\/wp-json\/wp\/v2\/publication\/2105\/revisions"}],"predecessor-version":[{"id":2106,"href":"https:\/\/bukka.phar.kyushu-u.ac.jp\/wp-json\/wp\/v2\/publication\/2105\/revisions\/2106"}],"wp:attachment":[{"href":"https:\/\/bukka.phar.kyushu-u.ac.jp\/wp-json\/wp\/v2\/media?parent=2105"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}